CEO of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), Crockett Thomas Andrew, sells 8,933 shares worth $268,480
According to KalVista Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 11 07:29 PM, company CEO, Crockett Thomas Andrew disclosed selling 8,933 shares at a cost of $30.05. At the time of this transaction (Jun 09), this trade was worth $268,480 in total. As of Jun 09, Crockett Thomas Andrew now owns 145,737 shares in total worth about $4,143,302.91.
For the last few recent trades made by KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) CEO, Crockett Thomas Andrew, we have the following information:
- SEC Form 4 filing: Apr 01: Sold 10,000 shares at the rate of $27.44 per share. Total worth of this trade was $274,436. Total number of shares owned as of Apr 01 were 159,420
- SEC Form 4 filing: Feb 23: Sold 10,000 shares at the rate of $33.55 per share. Total worth of this trade was $335,538. Total number of shares owned as of Feb 23 were 169,420
- SEC Form 4 filing: Jan 04: Sold 10,000 shares at the rate of $18.19 per share. Total worth of this trade was $181,904. Total number of shares owned as of Jan 04 were 185,420
Posted by
George Daniels
on Monday June 14 2021, 12:17 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
